Back to search results

Early Intervention in Plaque Psoriasis: is Bimekizumab Able to Delay Chronic Inflammation?

Abroad (travel likely)RecruitingPHASE2

Conditions

Psoriasis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • CHU de Nice - Hôpital de l'Archet, Nice, Alpes-Maritimes, France

    Contact: Study coordinator (Thierry Passeron, PhD) · passeron.t@chu-nice.fr · +33492036488
    Contact: Principal Investigator (Thierry Passeron, PhD)

  • Hôpital Edouard Herriot, Lyon, France

    Contact: Study coordinator (Axel VILLANI, PHD) · axel.villani@chu-lyon.fr · +33472117211
    axel VILLANI, PhD (Sub-investigator)

  • Hôpital Saint-Joseph, Marseille, France

    Contact: Study coordinator (Nathalie QUILES-TSIMARATOS, Ph) · nquiles@hopital-saint-joseph.fr · +33491806625
    Nathalie QUILES (Sub-investigator)

  • Cabinet Dermatologie Dr RUER, Martigues, France

    Contact: Study coordinator (Mireille RUER, Ph) · ruerdoc@gmal.com · +33661944503
    Mireille RUER (Sub-investigator)

  • CHU Saint-Etienne, Saint-Etienne, France

    Contact: Study coordinator (Jean-Luc PERROT, PhD) · j.luc.perrot@chu-st-etienne.fr · +33477828508
    Jean-Luc Perrot, PhD (Sub-investigator)

  • CHITS, Toulon, France

    Contact: Study coordinator (Thierry BOYE) · thierry.boye@yahoo.fr · +33483162569
    Thierry BOYE, Ph (Sub-investigator)

  • Médipole Villeurbanne, Villeurbanne, France

Study leads

  • Thierry Passeron, PhD

    Principal Investigator

    CHU de Nice, Service de Dermatologie

View source on ClinicalTrials.gov(opens in a new tab)